Has Asma Virani received payments from drug or device companies?

Yes. Drug and device makers reported $2,462 in general payments to Asma Virani across 135 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Asma Virani did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Asma Virani come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Asma Virani

Psychiatry · Houston, TXNPI 1407611577

Payments from drug & device makers

$2,462in general payments, 2019–2025

Across 135 payments — averaging $18.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$491
Otsuka America Pharmaceutical, Inc.$380
Lundbeck LLC$229
Johnson & Johnson$217
Axsome Therapeutics, Inc.$180
Supernus Pharmaceuticals, Inc.$177
plus $790 from 10 others

What the payments were for

Food & beverage$2,455100%
Education$80%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	30	$491
Otsuka America Pharmaceutical, Inc.	20	$380
Lundbeck LLC	13	$229
Johnson & Johnson	8	$217
Axsome Therapeutics, Inc.	6	$180
Supernus Pharmaceuticals, Inc.	16	$177
Vanda Pharmaceuticals Inc.	9	$154
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	9	$141
Takeda Pharmaceuticals U.S.A., Inc.	6	$116
Corium, LLC	4	$80
E.r. Squibb & Sons, L.L.C.	3	$77
Neurocrine Biosciences, Inc.	3	$75
Teva Pharmaceuticals USA, Inc.	3	$60
Collegium Pharmaceutical, Inc.	2	$36
Ironshore Pharmaceuticals Inc.	2	$32
Almatica Pharma LLC	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Auvelity$121
SPRAVATO$105

How this compares

$2,462 in reported general payments places this provider in the 75th percentile of 2,238 psychiatry providers in Texas.

See all psychiatry providers in Texas →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Lurasidone Hcl	16	$8,280
Atomoxetine Hcl	13	$1,890
Bupropion XlBupropion Hcl	48	$968
Quetiapine Fumarate	53	$685
Aripiprazole	20	$560
Buspirone Hcl	82	$477
Duloxetine Hcl	40	$460
Venlafaxine Hcl ErVenlafaxine Hcl	36	$433
Olanzapine	16	$396
Lamotrigine	28	$359
Clonazepam	49	$329
Risperidone	16	$308
Trazodone Hcl	69	$302
Hydroxyzine Hcl	34	$275
Alprazolam	39	$224

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Almatica Pharma LLCSertraline Hcl	$19	$21047 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,238 psychiatry providers in Texas.

Other psychiatry in Houston

Matthew BramsHouston$3M
Lawrence GinsbergHouston$2.4M
Asim ShahHouston$2.2M
Aqeel HashmiHouston$1.3M
Robert EarleHouston$1.1M
Frank ChenHouston$941K
Joao de QuevedoHouston$890K
Alice MaoHouston$850K
Mazhar KhowajaHouston$843K
Barry GritzHouston$792K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →